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Due to the diversity of measurement metrics employed in previous literature, the 
relevant literature was classified into three categories (Table 1) based on their utility in validating 
the regression models of the pulmonary artery (PA) diameter as a function of BSA or age in 
Fontan patients. The studies that fall into the first category reported mean LPA and RPA 
diameters directly. The studies that comprise the second category reported findings in 
normalized metrics from which the mean PA diameter data needed to be derived, therefore we 
constructed a procedure as outlined in Figure S1 and explained below to extract the necessary 
data. The third is comprised of those studies that reported median data and could not be used 
for the validation process.  
The Pulmonary Artery Index (PAI) is a normalized metric originally proposed by Nakata et 
al.[1] to serve as a prognostic indicator in the optimal selection of single ventricle patients for the 
Fontan palliation and is defined as: 
 




Where 𝑃𝑃𝑃𝑃𝑃𝑃𝑟𝑟 is the right PA area and 𝑃𝑃𝑃𝑃𝑃𝑃𝑙𝑙  is the left PA area. Equation (1) may be re-written as: 
 





Where the 𝑃𝑃𝑃𝑃 𝑃𝑃𝐴𝐴𝐴𝐴𝐴𝐴����������� is the average of the left and right PA area. The mean PA diameter is 
then determined from 𝑃𝑃𝑃𝑃 𝑃𝑃𝐴𝐴𝐴𝐴𝐴𝐴�����������  assuming the cross-section of the PA to be circular, provided 
the BSA is known. Tatum and colleagues[2] report  mean BSA and mean age for their cohort at 
the initial and follow-up measurement and hence the information from this study was used to 
validate both Model-BSA and Model-Age.  
Buheitel et al.[3] presented their measurements as systolic z-scores which are normalized 
against the mean PA size expected in healthy children. The CDC growth charts[4] were utilized to 
calculate the mean normal BSA at any age and this data was then applied to the normal PA growth 
curves reported by Rammos et al.[5] to obtain the mean normal PA size at any age. The mean 
normal PA size was used to de-normalize the z-scores and obtain the mean measured PA 
diameter at systole. Since Buheitel and colleagues only reported the mean age of their cohort, 
the data reported by this study was used to validate Model-Age only. 
 Some investigators such as Buheitel et al.[3] have measured and reported systolic PA 
diameters rather than the mean diameter (average of the systolic and diastolic diameter). The 
definition of distensibility (as defined by Bossers et al. [6]) was employed to determine the 
diastolic diameter (Equation 3), which we then used to find the mean (with regard to systole and 
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diastole) diameter. Of the investigations that have examined PA distensibility in Fontan patients 
(Table S2), the study conducted by Bossers et al.[6] reports the highest patient sample size. Based 
on their findings, we used a value of 0.15 for distensibility in our calculations according to their 
report. 
  





Where 𝑃𝑃𝑚𝑚𝑚𝑚𝑚𝑚  is the systolic diameter and 𝑃𝑃𝑚𝑚𝑚𝑚𝑚𝑚 is the diastolic diameter.  
 
Results and Discussion: 
The break point analysis with BSA as the response variable and age as the independent 
variable yielded a value of 17.5 years with a standard error of 1.1 years for the entire cohort. 
Partitioning the data at 17.5 years, we found a statistically significant, strong positive correlation 
(p<0.05, r=0.96, n=13) between the BSA and age below the age of 17.5 (Figure S2). Beyond the 
age of 17.5 years, the slope the regression line was not significant (p=0.265).  
Below the age of 17 years, BSA and age show a strong correlation indicating that age may 
serve well as a surrogate for the BSA. However, the dataset for the BSA-age correlation below 
the age of 17 years contains only ECC patients, since the age range for the non-ECC group was 
between 17.7 and 40.2. The presence of a breakpoint at approximately 17 years of age for the 
BSA-Age relation is consistent with the observation of a breakpoint at approximately 17 years for 
Model 2. 
In the case of the non-ECC group, since dataset included only adults (age range 17.7 to 
40.2), we performed comparisons between the adults of the ECC group and the non-ECC group. 
For the linear regression models obtained from the non-ECC group and the adults of the ECC 
group, where mean PA diameter was the response variable and BSA the explanatory variable, we 
observed a strong positive linear correlation for the ECC group and no correlation for the non-
ECC group (Table S3). The disparity in the correlations between mean PA diameter and BSA for 
the adult ECC patients and adult non-ECC patients is substantial and warrants further 
investigation. Owing to the prevalent adoption of the ECC variation of the Fontan procedure 
however, it may be difficult to acquire the pertinent data to investigate this observation. 
A representative measurement of the PA on which the size predicted by Model-BSA and 
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Table S1: Detailed Patient History 
Study # History Fenestration 
f001 Tricuspid atresia, bilateral SVCs No 
f002 Unbalanced complete AVSD. Left AV valve regurgitation, single SVC Yes 
f003 ccTGA, mitral atresia with DORV and PVS NA 
f004 DORV, mitral atresia ND 
f005 DILV ND 
f006 DORV, TGA, single SVC NA 
f007a Dextrocardia with DORV and PS, bilateral SVCs No 
f007b Dextrocardia with DORV and PS, bilateral SVCs No 
f008 
Left atrial isomerism, dextrocardia, unbalanced AVSD with interrupted 
IVC No 
f009 DILV, DORV Yes 
f010c Dextrocardia, left atrial isomerism, common AV valve NA 
f011a Dextrocardia, right atrial isomerism, unbalanced AV septal defect ND 
f012a TGA, interrupted aortic arch ND 
f012b TGA, interrupted aortic arch ND 
f012c TGA, interrupted aortic arch ND 
f013 occlusion device at LPA, tricuspid atresia, single SVC NA 
f014 DORV, DIRV, VSD, single SVC ND 
f015 ccTGA, mitral atresia, PVS, single SVC NA 
f016a HLHS ND 
f017 DILV, TGA, subaortic stenosis NA 
f018a DORV, Pulmonary atresia, bilateral SVCs NA 
f018b DORV, Pulmonary atresia, bilateral SVCs NA 
f019 DILV, DORV, PVS, single SVC No 
f020 DILV, Hypoplastic RV NA 
f021 
Left atrial isomerism, unbalanced AV septal defect, hypoplastic LV, 
bilateral SVCs No 
f022 Aortic atresia, VSD, single SVC Yes 
f023 DILV, hypoplastic RV, pulmonary atresia NA 
f024 
Pulmonary atresia, AV discordance, absent left atrioventricular 
connection NA 
f025 DILV ND 
f026b HLHS No 
f026c HLHS No 
f027 Tricuspid atresia, VSD ND 
f028a ccTGA, Subaortic stenosis, interrupted arch ND 
f028b ccTGA, Subaortic stenosis, interrupted arch ND 
f029a TGA, VSD, coarctation ND 
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f029b TGA, VSD, coarctation ND 
f030 HLHS, coarctation, right hemi-anomalous pulmonary venous return Yes 
f031 PAIVS with coronary fistulae Yes 
f033a HLHS Yes 
f034a HLHS Yes 
f035 Unspecified single left ventricle NA 
f037 Mitral atresia NA 
f038 HLHS Yes 
f040 DILV NA 
f042a DILV, VA discordance, VSD, Coarctation NA 
f042b DILV, VA discordance, VSD, Coarctation NA 
f043 DILV No 
f044 ccTGA, Truncus with atresia No 
f045 DILV, Hypoplastic left AV valve No 
f046 DILV No 
f047a HLHS Yes 
f048a Tricuspid atresia NA 
f048b Tricuspid atresia NA 
f049a Tricuspid atresia NA 
ND, No data available; SVC, Superior Vena Cava; AVSD, Atrioventricular Septal Defect; AV 
Atrioventricular; TGA, Transposition of the Great Arteries; ccTGA, Congenitally corrected 
Transposition of the Great Arteries; DORV, Double Outlet Right Ventricle; PVS, Pulmonary Valve 
Stenosis; VSD, Ventricular Septal Defect; RV, Right Ventricle; DILV, Double Inlet Left Ventricle; HLHS, 




Table S2: A summary of publications reporting mean distensibility data for pulmonary arteries in 
Fontan patients 
Ref No. Authors Sample Size Distensibility LPA Distensibility 
RPA 
Distensibility 
[7]* Morgan et al.(RA Group) 
(1998) 6  -  0.41 0.45 
[7]* Morgan et al.(BC 
Group)(1998) 5  -  0.37 0.33 
[8] 
Robbers-Visser et al. 
(2008) 
14   0.22  - -  
[6] Bossers et al. (2016) 23   0.15  - -  
LPA, Left Pulmonary Artery; RPA, Right Pulmonary Artery; 






A comparison of linear regression models fitted to the adult non-ECC group and adult ECC patients. In 
both cases, the explanatory variable is BSA and the response variable is the PA diameter. The p-value 
provided is for the individual F-test of the corresponding parameter estimate. 






ECC 11 Slope 16.34 2.94 10.58 22.1 0.0003 0.88 
 Adult 

























SUPPLEMENTARY FIGURE LEGENDS: 
Figure S1: Literature data extraction and compilation workflow. PA, pulmonary artery ; BSA, body 
surface area; PAI, Pulmonary Artery Index. 
 
Figure S2: Correlations between the body surface area and age for the entire cohort and the 
corresponding 95% confidence intervals (shaded regions). The breakpoint was determined to be 
17.5 years (standard error = 1.1 years).  
 
Figure S3: Section view of the PA of a representative Fontan patient. The size of the PA predicted 
by Model-BSA is shown in blue and the 95% confidence interval for the prediction is shown in 
orange. 
 
